Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. (Q40810992)

23 September 2017

Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. (English)

1 reference

23 September 2017

K Spring

7

0 references

Ygal Haupt

object named as

Y Haupt

4

0 references

author name string

I Fillippovich

1

1 reference

23 September 2017

N Sorokina

2

1 reference

23 September 2017

M Gatei

3

1 reference

23 September 2017

K Hobson

5

1 reference

23 September 2017

E Moallem

6

1 reference

23 September 2017

M Mould

8

1 reference

23 September 2017

M A McGuckin

9

1 reference

23 September 2017

M F Lavin

10

1 reference

23 September 2017

K K Khanna

11

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

23 September 2017

1 reference

23 September 2017

20

1 reference

23 September 2017

4

1 reference

23 September 2017

514-522

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204118

23 September 2017

0 references

cites work

Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Two new p73 splice variants, gamma and delta, with different transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Induction of apoptosis in HeLa cells by trans-activation-deficient p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

p73 is a simian [correction of human] p53-related protein that can induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Oncogenic forms of p53 inhibit p53-regulated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

The regulation of p53 function: Steiner Award Lecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Viral oncoproteins discriminate between p53 and the p53 homolog p73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Cloning and functional analysis of human p51, which structurally and functionally resembles p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

A model for p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

A novel protein with strong homology to the tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Biological activities of p53 mutants in Burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Non-p53 p53RE binding protein, a human transcription factor functionally analogous to P53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

7 January 2021

Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

7 January 2021

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

7 January 2021

Loss of imprinting and allele switching of p73 in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

7 January 2021

An anti-apoptotic role for the p53 family member, p73, during developmental neuron death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204118

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204118

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference